A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...
Investor's Business Daily on MSN
Why Gene-Editing Giants Crispr Therapeutics And Intellia Therapeutics Diverged
Crispr stock reversed lower Monday, while Intellia stock surged, on promising updates for their gene-editing efforts.
Morning Overview on MSN
Crispr reveals a new way to defeat resistant lung cancer
Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...
CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
News-Medical.Net on MSN
Innovative CRISPR strategy resensitizes lung cancer to treatment
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
In all, Preventive has quietly raised roughly $30 million from high-profile Silicon Valley names, including Coinbase CEO ...
Using CRISPR gene editing technology, researchers from Jiangnan University in China took a fungus that is already used as a ...
Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback